Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Acorda Therapeutics Inc (NASDAQ:ACOR)

34.36
Delayed Data
As of Jul 31
 +0.13 / +0.38%
Today’s Change
28.26
Today|||52-Week Range
45.45
-15.93%
Year-to-Date

Today’s Trading

Previous close34.23
Today’s open34.75
Day’s range33.47 - 34.75
Volume488,739
Average volume (3 months)562,802
Market cap$1.5B
Dividend yield--
Data as of 3:59pm ET, 07/31/2015

Growth & Valuation

Earnings growth (last year)+7.69%
Earnings growth (this year)-207.41%
Earnings growth (next 5 years)+37.00%
Revenue growth (last year)+19.34%
P/E ratio105.2
Price/Sales4.33
Price/Book2.66

Competitors

 Today’s
change
Today’s
% change
IRWDIronwood Pharmaceuti...-0.02-0.19%
NLNKNewLink Genetics Cor...+0.99+1.94%
ZSPHZS Pharma Inc+0.91+1.55%
EGRXEagle Pharmaceutical...-0.16-0.17%
Data as of 3:59pm ET, 07/31/2015

Financials

Next reporting dateNovember 3, 2015
EPS forecast (this quarter)-$0.13
Annual revenue (last year)$401.5M
Annual profit (last year)$17.7M
Net profit margin4.40%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Ronald Cohen
Chief-
Business Operations
David Lawrence
Corporate headquarters
Ardsley, New York

Forecasts